Clinical Trials Logo

Gout Flare clinical trials

View clinical trials related to Gout Flare.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06273813 Not yet recruiting - Acute Pain Clinical Trials

Treatment of Topical Ketorolac Gel in Acute Gouty Flare

Start date: February 2024
Phase: Phase 1
Study type: Interventional

This study will be a phase 1, open-label, bioavailability, safety and PK study of topically applied transcutaneous ketorolac tromethamine gel 12.5% (/w) (NOV-1776) versus intravenous administration of approved ketorolac tromethamine injection, USP (15mg/mL) comparator in healthy volunteers, including an evaluation of safety, tolerability, and efficacy in gout participants with flare-up.

NCT ID: NCT06207045 Not yet recruiting - Gout Flare Clinical Trials

The Effects of Limb Elevation During Gout Flare Episodes

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The goal of this open-label randomized controlled trial is to explore the benefit of limb elevation in inpatient gout flare episodes, compared with standard treatment The main questions are; - Is limb elevation able to reduce pain during gout flare episodes to a greater degree compared with standard treatment ? - Is Is limb elevation able to reduce joint swelling during gout flare episodes to a greater degree compared with standard treatment ? Participants will be divided into 2 group; 1. Limb elevation group 2. control group All participants will receive standard medical therapy consisting of colchicine 0.6 mg per day plus prednisolone 30 mg per day for 2 days Pain score and joint circumference will be recored at recruitment, 24 hour and 48 hour

NCT ID: NCT04849312 Not yet recruiting - Asthma Clinical Trials

Prediction of 30-Day Readmission Using Machine Learning

Start date: March 20, 2022
Phase:
Study type: Observational

This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict the likelihood of 30-day readmission throughout a patient's admission. This algorithm was then validated in a validation cohort.

NCT ID: NCT04069325 Not yet recruiting - Gout Flare Clinical Trials

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy and safety of simiaowan in prevention of acute flares in chronic gout patients initiating febuxostat therapy.